id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2021-D-0368-0012,FDA,FDA-2021-D-0368,"Investigator Responsibilities—Safety Reporting for Investigational Drugs and Devices; Guidance for Investigators, Industry, and Institutional Review Boards; Availability",Notice,Notice of Availability,2025-12-16T05:00:00Z,2025,12,2025-12-16T05:00:00Z,,2025-12-16T18:17:17Z,2025-22869,0,0,09000064b90da8c2
FDA-2021-D-0368-0013,FDA,FDA-2021-D-0368,"Investigator Responsibilities — Safety Reporting for Investigational Drugs and Devices; Guidance for Investigators, Industry, and Institutional Review Boards - Final Guidance",Other,Guidance,2025-12-16T05:00:00Z,2025,12,2025-12-16T05:00:00Z,,2026-02-07T13:13:23Z,,1,0,09000064b90dcdf0
FDA-2021-D-0368-0001,FDA,FDA-2021-D-0368,"Investigator Responsibilities—Safety
Reporting for Investigational Drugs
and Devices; Draft Guidance for
Industry; Availability",Notice,Notice of Availability,2021-09-30T04:00:00Z,2021,9,2021-09-30T04:00:00Z,2021-11-30T04:59:59Z,2021-11-30T02:00:39Z,2021-21316,0,0,0900006484db3ae2
FDA-2021-D-0368-0002,FDA,FDA-2021-D-0368,Investigator Responsibilities — Safety Reporting for Investigational Drugs and Devices Guidance for Industry DRAFT GUIDANCE,Other,Guidance,2021-09-30T04:00:00Z,2021,9,2021-09-30T04:00:00Z,,2025-12-16T18:37:00Z,,0,0,0900006484db408a